Status | Study |
Not yet recruiting |
Study Name: Pegteograstim in Children With Solid Tumors Condition: Chemotherapy Induced Neutropenia Pediatric Solid Tumor Date: 2016-05-24 Interventions: Drug: Pegteograstim |
Recruiting |
Study Name: Home Away From Home - Medical Outcomes Condition: Acute Myeloid Leukemia Neutropenia Bacteremia Date: 2016-05-13 |
Completed |
Study Name: A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) Condition: Neutropenia (Low White Blood Cell Count) Date: 2016-05-06 Interventions: Biological: Filgrastim Hospira (US) |
Completed |
Study Name: A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) Condition: Neutropenia (Low White Blood Cell Count) Date: 2016-05-06 Interventions: Biological: Filgrastim Hospira (US) |
Not yet recruiting |
Study Name: The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia Condition: Breast Cancer Date: 2016-04-28 Interventions: Drug: PEG-rhG-CSF PEG-rhG-CSF 6mg is given for patients Greater than or equal to 45 kg, 3mg is given for |
Not yet recruiting |
Study Name: Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis Condition: Neutropenia Date: 2016-04-28 Interventions: Drug: Lozanoc 65 mg Other Name: itraconazole |
Recruiting |
Study Name: S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Condition: Febrile Neutropenia Stage 0 Breast Cancer Stage 0 Colorect Date: 2016-03-30 Interventions: Other: Preventive Intervention |
Recruiting |
Study Name: Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer Condition: Chemotherapy-induced Neutropenia Date: 2016-03-24 Interventions: Biological: Pegylated Recombinant Human G-CSF |
Terminated |
Study Name: Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer Condition: Neoplasms Febrile Neutropenia Date: 2016-03-18 Interventions: Drug: CAZ-AVI Ceftazidime-Avib |
Completed |
Study Name: Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis Condition: Breast Cancer Date: 2016-03-17 Interventions: Drug: CBLB612 4 μg CBLB61 |